Featured
-
-
Q&A |
From R&D to I&D
The career paths of Alveda Williams and Cory Valente have closely mirrored each other — perhaps surprisingly so for a straight Black woman and a gay white man with very different childhoods. They talk to Nature Chemistry about their journeys from research and development roles to Dow’s inclusion and diversity team.
- Anne Pichon
-
Comment |
Harder, better, faster
The gap between fundamental academic research and the applied industrial research that is necessary to ensure real-world applications can be bridged by engaging in well-defined collaborative academia–industry projects and fostering better communication between the scientists involved in them.
- Danielle Schultz
- & Louis-Charles Campeau
-
Editorial |
Frameworks for commercial success
Taking chemical technology from the bench to the consumer is a formidable challenge, but it is how research can ultimately benefit wider society. Companies are now beginning to incorporate metal–organic frameworks into commercial products, heralding a new era for the field.
-
Interview |
MOFs move to market
Omar Farha (Chief Science Officer & technical founder) and Ben Hernandez (Chief Executive Officer) of NuMat Technologies, talk to Nature Chemistry about the release of one of the first MOF-based commercial products and the challenges the journey posed.
- Thomas Faust
-
Thesis |
Salt of the Earth
Chemical compounds are often taken for granted, argues Bruce Gibb, and the most underappreciated is one that we're all very familiar with.
- Bruce C. Gibb
-
Commentary |
The changing landscape of careers in the chemical industry
Changes in the chemical industry over the past decade — ranging from globalization to an increased focus on speciality chemicals — threaten to leave the aspiring industrial chemist unprepared. This Commentary discusses those changes and outlines strategies to enter the job market as well equipped as possible.
- Keith J. Watson
-
-
Editorial |
A bitter pill
Cuts in pharmaceutical R&D jobs might provide short-term improvements to the bottom line, but do not bode well for the industry in the long run.